Delivery Order SPE2DR25D2011-SPE2DR26FADQR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,856.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 12, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,092.83 on December 15, 2025, for the supply of Trulicity 3 mg/0.5 ml pens with a completion date of December 16, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,250.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 18, 2025, with completion scheduled for December 19, 2025. This non-competitive delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,943.99 to supply Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $15,036.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a non-set-aside award issued under a competitive procurement process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical supply needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a $1,769.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $5,657 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens in 0.5 ml quantities. This firm fixed price, non-set-aside contract is scheduled for completion by December 12, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,523.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, non-set-aside contract represents a single delivery order fulfillment with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $2,180.40. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement and is due for completion by December 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADQRDelivery Order
The Defense Logistics Agency awarded a $4,585.75 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitive award, which is not set-aside and utilizes firm fixed pricing, is scheduled for completion by December 22, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.999 billion and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, including diabetes medications, specialty treatments, and medical devices. This particular delivery order for Trulicity, a commonly prescribed diabetes medication, reflects the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through competitive federal contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 12/18/25 |